Immune modulation property of Lactobacillus paracasei NCC2461 (ST11) strain and impact on skin defences

Beneficial Microbes

Volumn 5, Issue 2, 2014, Pages 129-136

  Benyacoub, J ^a   Bosco, N ^a   Blanchard, C ^a   Demont, A ^a   Philippe, D ^a   Castiel Higounenc, I ^b   Gueniche A ^c  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b L'Oreal Research and Innovation   (France)

^c L ORÉAL RECHERCHE   (France)

Author keywords

Gut skin axis; Microbiota; Probiotic; ST11

Indexed keywords

PROBIOTIC AGENT;

BIFIDOBACTERIUM ANIMALIS; CELLULAR IMMUNITY; CYTOKINE RELEASE; CYTOKINE RESPONSE; DRUG SAFETY; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOMODULATION; INTESTINE FLORA; LACTOBACILLUS PARACASEI; MICROBIAL ACTIVITY; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; SKIN FUNCTION; SKIN SENSITIVITY;

GUT-SKIN AXIS; MICROBIOTA; PROBIOTIC; ST11;

GASTROINTESTINAL TRACT; LACTOBACILLUS; PROBIOTICS; SKIN;

EID: 84897977784     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2013.0014     Document Type: Review

References (60)

1. Aagaard, K., Petrosino, J., Keitel, W., Watson, M., Katancik, J., Garcia, N., Patel, S., Cutting, M., Madden, T., Hamilton, H., Harris, E., Gevers, D., Simone, G., Mcinnes, P. and Versalovic, J., 2013. The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. The FASEB Journal 27: 1012-1022.
2. Bergonzelli, G.E., Blum, S., Brussow, H. and Corthesy-Theulaz, I., 2005. Probiotics as a treatment strategy for gastrointestinal diseases? Digestion 72: 57-68.
3. Bernet-Camard, M.F., Lievin, V., Brassart, D., Neeser, J.R., Servin, A.L. and Hudault, S., 1997. The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Applied and Environmental Microbiology 63: 2747-2753.
4. Bunout, D., Barrera, G., Hirsch, S., Gattas, V., De la Maza, M.P., Haschke, F., Steenhout, P., Klassen, P., Hager, C., Avendano, M., Petermann, M. and Munoz, C., 2004. Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. Journal of Parenteral and Enteral Nutrition 28: 348-354.
5. Cebra, J.J., 1999. Influences of microbiota on intestinal immune system development. American Journal of Clinical Nutrition 69: 1046S-1051S.
6. Chouraqui, J.P., Grathwohl, D., Labaune, J.M., Hascoet, J.M., de Montgolfier, I., Leclaire, M., Giarre, M. and Steenhout, P., 2008. Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial. American Journal of Clinical Nutrition 87: 1365-1373.
7. Chow, J., Tang, H. and Mazmanian, S.K., 2011. Pathobionts of the gastrointestinal microbiota and inflammatory disease. Current Opinion in Immunology 23: 473-480.
8. Coconnier, M.H., Bernet, M.F., Chauviere, G. and Servin, A.L., 1993a. Adhering heat-killed human Lactobacillus acidophilus, strain LB, inhibits the process of pathogenicity of diarrhoeagenic bacteria in cultured human intestinal cells. Journal of Diarrhoeal Diseases Research 11: 235-242.
9. Coconnier, M.H., Bernet, M.F., Kerneis, S., Chauviere, G., Fourniat, J. and Servin, A.L., 1993b. Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiology Letters 110: 299-305.
10. Coconnier, M.H., Lievin, V., Hemery, E. and Servin, A.L., 1998. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Applied and Environmental Microbiology 64: 4573-4580.
11. El Aidy, S., Van Baarlen, P., Derrien, M., Lindenbergh-Kortleve, D.J., Hooiveld, G., Levenez, F., Dore, J., Dekker, J., Samsom, J.N., Nieuwenhuis, E.E. and Kleerebezem, M., 2012. Temporal and spatial interplay of microbiota and intestinal mucosa drive establishment of immune homeostasis in conventionalized mice. Mucosal Immunology 5: 567-579.
12. Elmer, G.W., 2001. Probiotics: 'living drugs'. American Journal of Health-System Pharmacy 58: 1101-1109.
13. Fuller, R., 1989. Probiotics in man and animals. Journal of Applied Bacteriology 66: 365-378.
14. Gareau, M.G., Sherman, P.M. and Walker, W.A., 2010. Probiotics and the gut microbiota in intestinal health and disease. Nature Reviews Gastroenterology and Hepatology 7: 503-514.
15. Gueniche, A., Benyacoub, J., Philippe, D., Bastien, P., Kusy, N., Breton, L., Blum, S. and Castiel-Higounenc, I., 2010. Lactobacillus paracasei CNCM I-2116 (ST11) inhibits substance P-induced skin inflammation and accelerates skin barrier function recovery in vitro. European Journal of Dermatology 20: 731-737.
16. Gueniche, A., Philippe, D., Bastien, P., Reuteler, G., Blum, S., Castiel- Higounenc, I., Breton, L. and Benyacoub, J., in press. Placebocontrolled study on the effect of Lactobacillus paracasei Cncm I-2116 (st11) on skin reactivity. Beneficial Microbes. DOI: http://dx.doi.org/10.3920/BM2013.0001.
17. Hashimoto, K., 2000. Regulation of keratinocyte function by growth factors. Journal of Dermatological Science 24 Suppl. 1: S46-S50.
18. Ibnou-Zekri, N., Blum, S., Schiffrin, E.J. and Von der Weid, T., 2003. Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infection and Immunity 71: 428-436.
19. Isolauri, E., Sutas, Y., Kankaanpaa, P., Arvilommi, H. and Salminen, S., 2001. Probiotics: effects on immunity. American Journal of Clinical Nutrition 73: 444S-450S.
20. Jourdain, R., De Lacharriere, O., Bastien, P. and Maibach, H.I., 2002. Ethnic variations in self-perceived sensitive skin: epidemiological survey. Contact Dermatitis 46: 162-169.
21. Kalliomaki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P. and Isolauri, E., 2001. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. The Lancet 357: 1076-1079.
22. Kalliomaki, M., Salminen, S., Poussa, T., Arvilommi, H. and Isolauri, E., 2003. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. The Lancet 361: 1869-1871.
23. Krutmann, J., Ahrens, C., Roza, L. and Arlett, C.F., 1996. The role of DNA damage and repair in ultraviolet B radiation-induced immunomodulation: relevance for human photocarcinogenesis. Photochemistry and Photobiology 63: 394-396.
24. Langhendries, J.P., Detry, J., Van Hees, J., Lamboray, J.M., Darimont, J., Mozin, M.J., Secretin, M.C. and Senterre, J., 1995. Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants. Journal of Pediatric Gastroenterology and Nutrition 21: 177-181.
25. Leonardi, C.L., Kimball, A.B., Papp, K.A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L.T., Gordon, K.B. and PHOENIX 1 study investigators, 2008. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebocontrolled trial (PHOENIX 1). The Lancet 371: 1665-1674.
26. Leveque, J.L., Ribaud, C. and Garson, J.C., 1992. [Biophysical characterization of the stratum corneum. Relationship between structure and properties]. Pathologie Biologie 40: 95-108.
27. Lomax, A.R. and Calder, P.C., 2009. Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans. Current Pharmaceutical Design 15: 1428-1518.
28. Macpherson, A.J. and Harris, N.L., 2004. Interactions between commensal intestinal bacteria and the immune system. Nature Reviews Immunology 4: 478-485.
29. Marionnet, C., Bernerd, F., Dumas, A., Verrecchia, F., Mollier, K., Compan, D., Bernard, B., Lahfa, M., Leclaire, J., Medaisko, C., Mehul, B., Seite, S., Mauviel, A. and Dubertret, L., 2003. Modulation of gene expression induced in human epidermis by environmental stress in vivo. Journal of Investigative Dermatology 121: 1447-1458.
30. Marriott, M., Holmes, J., Peters, L., Cooper, K., Rowson, M. and Basketter, D.A., 2005. The complex problem of sensitive skin. Contact Dermatitis 53: 93-99.
31. Menon, G.K., Cleary, G.W. and Lane, M.E., 2012. The structure and function of the stratum corneum. International Journal of Pharmaceutics 435: 3-9.
32. Misery, L., Myon, E., Martin, N., Verriere, F., Nocera, T. and Taieb, C., 2005. [Sensitive skin in France: an epidemiological approach]. Annales de Dermatologie et de Vénéréologie 132: 425-429.
33. Mohan, R., Koebnick, C., Schildt, J., Schmidt, S., Mueller, M., Possner, M., Radke, M. and Blaut, M., 2006. Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. Journal of Clinical Microbiology 44: 4025-4031.
34. Nickoloff, B.J. and Naidu, Y., 1994. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. Journal of the American Academy of Dermatology 30: 535-546.
35. Oliveira, M., Bosco, N., Perruisseau, G., Nicolas, J., Segura-Roggero, I., Duboux, S., Briand, M., Blum, S. and Benyacoub, J., 2011. Lactobacillus paracasei reduces intestinal inflammation in adoptive transfer mouse model of experimental colitis. Clinical and Developmental Immunology 2011: 807483.
36. Ouwehand, A., Isolauri, E. and Salminen, S., 2002. The role of the intestinal microflora for the development of the immune system in early childhood. European Journal of Nutrition 41 Suppl.: i32-i37.
37. Pasonen-Seppänen, S., Karvinen, S., Torronen, K., Hyttinen, J.M., Jokela, T., Lammi, M.J., Tammi, M.I. and Tammi, R., 2003. EGF upregulates, whereas TGF-beta downregulates, the hyaluronan synthases Has2 and Has3 in organotypic keratinocyte cultures: correlations with epidermal proliferation and differentiation. Journal of Investigative Dermatology 120: 1038-1044.
38. Pellaton, C., Nutten, S., Thierry, A.C., Boudousquie, C., Barbier, N., Blanchard, C., Corthesy, B., Mercenier, A. and Spertini, F., 2012. Intragastric and intranasal administration of Lactobacillus paracasei NCC2461 modulates allergic airway inflammation in mice. International Journal of Inflammation 2012: 686739.
39. Philippe, D., Blum, S. and Benyacoub, J., 2011. Oral Lactobacillus paracasei improves skin barrier function recovery and reduces local skin inflammation. European Journal of Dermatology 21: 279-280.
40. Pons-Guiraud, A., 2004. Sensitive skin: a complex and multifactorial syndrome. Journal of Cosmetic Dermatology 3: 145-148.
41. Primavera, G. and Berardesca, E., 2005. Clinical and instrumental evaluation of a food supplement in improving skin hydration. International Journal of Cosmetic Science 27: 199-204.
42. Rautava, S., Kainonen, E., Salminen, S. and Isolauri, E., 2012. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. Journal of Allergy and Clinical Immunology 130: 1355-1360.
43. Rautava, S., Kalliomäki, M. and Isolauri, E., 2002. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. Journal of Allergy and Clinical Immunology 109: 119-121.
44. Rescigno, M., Rotta, G., Valzasina, B. and Ricciardi-Castagnoli, P., 2001. Dendritic cells shuttle microbes across gut epithelial monolayers. Immunobiology 204: 572-581.
45. Roberfroid, M.B., Bornet, F., Bouley, C. and Cummings, J.H., 1995. Colonic microflora: nutrition and health. Summary and conclusions of an International Life Sciences Institute (ILSI) [Europe] workshop held in Barcelona, Spain. Nutrition Reviews 53: 127-130.
46. Rol, N., Favre, L., Benyacoub, J. and Corthesy, B., 2012. The role of secretory immunoglobulin A in the natural sensing of commensal bacteria by mouse Peyer's patch dendritic cells. Journal of Biological Chemistry 287: 40074-40082.
47. Sandborn, W.J., Feagan, B.G., Fedorak, R.N., Scherl, E., Fleisher, M.R., Katz, S., Johanns, J., Blank, M., Rutgeerts, P. and Ustekinumab Crohn's Disease Study, G., 2008. A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. Gastroenterology 135: 1130-1141.
48. Sarker, S.A., Sultana, S., Fuchs, G.J., Alam, N.H., Azim, T., Brüssow, H. and Hammarström, L., 2005. Lactobacillus paracasei strain ST11 has no effect on rotavirus but ameliorates the outcome of nonrotavirus diarrhea in children from Bangladesh. Pediatrics 116: e221-e228.
49. Schmelz, M. and Petersen, L.J., 2001. Neurogenic inflammation in human and rodent skin. News in Physiological Sciences 16: 33-37.
50. Seidenari, S., Francomano, M. and Mantovani, L., 1998. Baseline biophysical parameters in subjects with sensitive skin. Contact Dermatitis 38: 311-315.
51. Simakachorn, N., Bibiloni, R., Yimyaem, P., Tongpenyai, Y., Varavithaya, W., Grathwohl, D., Reuteler, G., Maire, J.C., Blum, S., Steenhout, P., Benyacoub, J. and Schiffrin, E.J., 2011. Tolerance, safety, and effect on the faecal microbiota of an enteral formula supplemented with pre- and probiotics in critically ill children. Journal of Pediatric Gastroenterology and Nutrition 53: 174-181.
52. Steinhoff, M., Stander, S., Seeliger, S., Ansel, J.C., Schmelz, M. and Luger, T., 2003. Modern aspects of cutaneous neurogenic inflammation. Archives of Dermatology 139: 1479-1488.
53. Uhlig, H.H. and Powrie, F., 2003. Dendritic cells and the intestinal bacterial flora: a role for localized mucosal immune responses. Journal of Clinical Investigation 112: 648-651.
54. Valacchi, G., Sticozzi, C., Pecorelli, A., Cervellati, F., Cervellati, C. and Maioli, E., 2012. Cutaneous responses to environmental stressors. Annals of the New York Academy of Sciences 1271: 75-81.
55. Vidal, K., Benyacoub, J., Moser, M., Sanchez-Garcia, J., Serrant, P., Segura-Roggero, I., Reuteler, G. and Blum, S., 2008. Effect of Lactobacillus paracasei NCC2461 on antigen-specific T-cell mediated immune responses in aged mice. Rejuvenation Research 11: 957-964.
56. Von der Weid, T., Bulliard, C. and Fritsche, R., 2001b. Suppression of specific and bystander IgE responses in a mouse model of oral sensitization to beta-lactoglobulin. International Archives of Allergy and Immunology 125: 307-315.
57. Von der Weid, T., Bulliard, C. and Schiffrin, E.J., 2001a. Induction by a lactic acid bacterium of a population of CD4+ T cells with low proliferative capacity that produce transforming growth factor ß and interleukin-10. Clinical and Diagnostic Laboratory Immunology 8: 695-701.
58. Wassenberg, J., Nutten, S., Audran, R., Barbier, N., Aubert, V., Moulin, J., Mercenier, A. and Spertini, F., 2011. Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis. Clinical and Experimental Allergy 41: 565-573.
59. Willis, C.M., Shaw, S., De Lacharriere, O., Baverel, M., Reiche, L., Jourdain, R., Bastien, P. and Wilkinson, J.D., 2001. Sensitive skin: an epidemiological study. British Journal of Dermatology 145: 258-263.
60. Zegarska, B., Lelinska, A. and Tyrakowski, T., 2006. Clinical and experimental aspects of cutaneous neurogenic inflammation. Pharmacological Reports 58: 13-21.